209 related articles for article (PubMed ID: 7220580)
21. [Biopharmaceutical study of aminophenazone-containing suppositories. 1. Experimental materials and methods, determination of physical qualities of the suppositories].
Tantó M; Ecsy Z; Selmeczi B; Regdon G
Acta Pharm Hung; 1990 Jul; 60(4):143-8. PubMed ID: 2239341
[TBL] [Abstract][Full Text] [Related]
22. In vitro drug liberation and kinetics of sustained release indomethacin suppository.
Uzunkaya G; Bergişadi N
Farmaco; 2003 Jul; 58(7):509-12. PubMed ID: 12818689
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of sustained release suppositories prepared with fatty base including solid fats with high melting points.
Takatori T; Shimono N; Higaki K; Kimura T
Int J Pharm; 2004 Jul; 278(2):275-82. PubMed ID: 15196632
[TBL] [Abstract][Full Text] [Related]
24. [Acetaminophen-containing suppositories in vitro and in vivo].
Regdon G; Szikszay M; Gebri G; Regdon G
Acta Pharm Hung; 1994 Mar; 64(2):45-9. PubMed ID: 8017207
[TBL] [Abstract][Full Text] [Related]
25. Release property of progesterone from a mixed-base suppository consisting of Witepsol W35 and Witepsol E85.
Iwata M; Komiya S; Nakamura K; Kiuchi M; Andoh N; Hirahara F; Maitani Y; Takayama K
Drug Dev Ind Pharm; 2001 Nov; 27(10):1039-45. PubMed ID: 11794806
[TBL] [Abstract][Full Text] [Related]
26. Preparation and evaluation of fenoterol hydrobromide suppositories.
Ghorab D; Refai H; Tag R
Drug Discov Ther; 2011 Dec; 5(6):311-8. PubMed ID: 22466443
[TBL] [Abstract][Full Text] [Related]
27. Effect of suppository bases on the release properties of a potent antimicrobial agent (C31G).
Caliş S; Sumnu M; Hincal AA
Pharmazie; 1994 May; 49(5):336-9. PubMed ID: 8016179
[TBL] [Abstract][Full Text] [Related]
28. Feasibility of the Ph.Eur. flow-through cell for dissolution testing of the compounded rectal suppositories containing indomethacin or sodium diclofenac.
Woyczikowski B; Szulc J; Sznitowska M; Janicki S; Pilichowski J; Urbańska A
Acta Pol Pharm; 2003; 60(3):169-72. PubMed ID: 14556483
[TBL] [Abstract][Full Text] [Related]
29. The effect of 2-hydroxypropyl-beta-cyclodextrin on in vitro drug release of steroids from suppository bases.
Usayapant A; Iyer BR
Drug Dev Ind Pharm; 1999 Mar; 25(3):387-90. PubMed ID: 10071835
[TBL] [Abstract][Full Text] [Related]
30. [Comparison of in vitro model examinaitons with respect to drug release from suppositories].
Regdon G; Vágó I; Mándi E; Regdon G; Erós I
Acta Pharm Hung; 2000 Apr; 70(2):45-51. PubMed ID: 11192740
[TBL] [Abstract][Full Text] [Related]
31. Preparation and In vitro Evaluation of Naproxen Suppositories.
Hargoli S; Farid J; Azarmi SH; Ghanbarzadeh S; Zakeri-Milani P
Indian J Pharm Sci; 2013 Mar; 75(2):143-8. PubMed ID: 24019561
[TBL] [Abstract][Full Text] [Related]
32. [Contributions to the liberation of drugs from suspension ointments. Part 12: On the suitability of some synthetic hydrophobic membranes for liberation studies (author's transl)].
Horsch W; Fürst W; Zerbe A; Finke I; Winter K; Richter H
Pharmazie; 1981; 36(1):24-8. PubMed ID: 7220582
[TBL] [Abstract][Full Text] [Related]
33. The release of isoconazole nitrate from different suppository bases: in-vivo release of drug labelled with 99mTc in rabbits.
Asikoglu M; Ertan G; Ercan MT; Duman Y
J Pharm Pharmacol; 1995 Sep; 47(9):717-20. PubMed ID: 8583381
[TBL] [Abstract][Full Text] [Related]
34. [Kinetics of liberation from suppository bases of phenobarbital acid and sodium and a semi-synthetic glyceride (Witepsol H 15). II. Suppositories after storage].
Lasserre Y; Peneva MB; Jacob M; Puech A; Sabatier R
Pharm Acta Helv; 1987; 62(10-11):287-91. PubMed ID: 3438314
[No Abstract] [Full Text] [Related]
35. Preparation and investigation of acetyl salicylic acid-caffeine complex for rectal administration.
Fouad EA; El-Badry M; Alanazi FK; Arafah MM; Al-Ashban R; Alsarra IA
Pharm Dev Technol; 2010 Jun; 15(3):249-57. PubMed ID: 22716465
[TBL] [Abstract][Full Text] [Related]
36. Formulation effects on the mechanical and release properties of metronidazole suppositories.
Adegboye TA; Itiola OA
Afr J Med Med Sci; 2003 Sep; 32(3):247-51. PubMed ID: 15030082
[TBL] [Abstract][Full Text] [Related]
37. New Formulation and Evaluation of Camptothecin Encapsulated and/or Dispersed Suppository.
Fatmi S; Taouzinet L; Lahiani-Skiba M; Skiba M; Iguer-Ouada M
Anticancer Agents Med Chem; 2021; 21(9):1183-1190. PubMed ID: 32885761
[TBL] [Abstract][Full Text] [Related]
38. Design of controlled-release morphine suppositories containing polyglycerol ester of fatty acid.
Takatori T; Yamamoto K; Yamaguchi T; Higaki K; Kimura T
Biol Pharm Bull; 2005 Aug; 28(8):1480-4. PubMed ID: 16079497
[TBL] [Abstract][Full Text] [Related]
39. Biopharmaceutical investigations of rectal suppositories. Part 1: Pharmaceutical and biological availability of theophylline.
Minkov E; Lambov N; Kirchev D; Bantutova I; Tencheva J
Pharmazie; 1984 Apr; 39(4):242-3. PubMed ID: 6547533
[TBL] [Abstract][Full Text] [Related]
40. [Effect of temperature on drug release and drug absorption in mixed type diclofenac sodium suppositories].
Iwata M; Takayama K; Takahashi Y; Obata Y; Machida Y; Nagai T; Shirotake S
Yakugaku Zasshi; 1999 Feb; 119(2):170-7. PubMed ID: 10067431
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
